| |
| |
|
| Insider
Information: |
Boyd Thomas A |
| Relationship: |
Sr. VP, Product Dev. |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
47,137 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$193,262 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,137 |
|
|
| Total
Value |
$193,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Sr. VP, Product Dev. |
2010-07-01 |
47,137 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$12,828 |
D/D |
(1,929) |
36,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-07-03 |
4 |
OE |
$20.45 |
$40,616 |
D/D |
1,986 |
18,789 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-11-15 |
4 |
AS |
$28.92 |
$57,864 |
D/D |
(2,000) |
33,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-11-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
35,079 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-12-15 |
4 |
AS |
$26.05 |
$52,100 |
D/D |
(2,000) |
33,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-12-15 |
4 |
OE |
$17.19 |
$34,380 |
D/D |
2,000 |
34,079 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-03-15 |
4 |
AS |
$22.77 |
$45,582 |
D/D |
(2,000) |
33,676 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-03-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
34,176 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-04-16 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
29,426 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-04-16 |
4 |
AS |
$26.81 |
$53,751 |
D/D |
(2,000) |
28,926 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-05-15 |
4 |
AS |
$21.90 |
$43,812 |
D/D |
(2,000) |
28,926 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-05-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
29,426 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-06-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
29,426 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-06-15 |
4 |
AS |
$22.02 |
$44,043 |
D/D |
(2,000) |
28,926 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-07-16 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
36,709 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-07-16 |
4 |
AS |
$21.36 |
$43,169 |
D/D |
(2,000) |
36,209 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-08-15 |
4 |
AS |
$22.85 |
$45,799 |
D/D |
(2,000) |
36,209 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-08-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
36,709 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-06-23 |
4 |
AS |
$4.73 |
$9,468 |
D/D |
(2,000) |
36,699 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-04-02 |
4 |
OE |
$20.13 |
$40,622 |
D/D |
2,018 |
35,745 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$38,612 |
D/D |
2,029 |
38,288 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
38,699 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-06-21 |
4 |
D |
$22.65 |
$48,689 |
D/D |
(2,150) |
26,776 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-04-01 |
4 |
D |
$5.36 |
$12,784 |
D/D |
(2,385) |
39,034 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-07-01 |
4 |
D |
$5.35 |
$12,851 |
D/D |
(2,402) |
37,137 |
0 |
- |
|
76 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
